头颈肿瘤精准放疗:基因组学,影像组学&免疫学( 二 )
英文原文
Precision Radiotherapy Approaches in Head and Neck Cancers-A Tripartite Marriage of Genomics, Radiomics, and Immunologics
Melvin Lee Kiang Chua
Clinician-Scientist, Consultant, Division of Radiation Oncology, National Cancer Centre Singapore
Topic: Precision Radiotherapy in Head and Neck Cancers: Genomics, Radiomics & Immunologics
Professor Melvin demonstrated the precision radiotherapy (RT) approaches for head and neck cancers (HNC) based on genomics, radiomics and immunologics. He emphasized the landscape change of HNC, especially the epidemic of human papilloma virus-positive oropharynx squamous cell carcinoma (HPV+ OPSCC). Virus-associated HNC is considered to be different from non-virus-associated HNC, and they found commonalities of genetic changes between TCGA HP+ HNC and Singapore Epstein-Barr virus-positive nasopharyngeal carcinoma (EBV+ NPC). Revised stage classification for HPV+ OPSCC had been proposed, but it has not yet been translated to a change in treatment paradigm for this disease. As for optimal RT dose fractionation, reported 5-year overall survival benefit of 8% with hyperfraction seemed equivalent to that from chemo-RT combination in Meta analysis. Hyperfraction RT might be a way to improve disease control for advanced disease unsuitable to receive chemo-radiotherapy. Recently, a novel precision RT concept, known as adaptive RT, has been proposed for improving the therapeutic ratio. The feasibility of adaptive RT is related to the onset of molecular and functional imaging, which offers information on molecular architecture of the tumour. Radiomics is a novel high throughput feature extraction and selection workflow to derive signatures for clinical prognostication and adapting RT based on real-time tumour changes. Additionally, the acute enthusiasm to incorporate immunotherapy in the management of cancers has also prompted the utility of immunotherapy-RT in HNC. Recent data suggests that genomics and radiomics have the potential to inform on the molecular processes underpinning responses to immunotherapy, and thereby facilitate better patient stratification.
- 科学家研究Omega-3如何抑制小鼠肿瘤生长
- 深圳科学家提出肿瘤精准治疗新思路
- 防癌|治癌近三十年,肿瘤专家却不敌胰腺癌,希望能给你敲响警钟
- 晚期癌症只能活活痛死?癌症根本不用治?肿瘤科医生讲了四个真相
- 癌症|治疗癌症,中医好还是西医好?肿瘤科医生讲到了根本上
- 不止mRNA,六种肿瘤疫苗及其优缺点
- 【衡道丨干货】纤维母细胞和肌纤维母细胞性肿瘤(上)
- 癌症|研究癌症一辈子,却劝人别轻易开刀,肿瘤院士的真心话需要用心听
- 打了HPV疫苗,还需要做筛查吗?看看妇科肿瘤权威专家怎么说
- 伴有NTRK融合突变的肝癌用对应靶向药三周期后肿瘤缩小3/4
